Viewing Study NCT00686868


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-02-03 @ 4:41 AM
Study NCT ID: NCT00686868
Status: COMPLETED
Last Update Posted: 2017-06-26
First Post: 2008-05-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis, Rheumatoid View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GSK1841157; View
None rheumatoid arthritis, View
None B-cell depletion View
None anti-CD20 monoclonal antibody, View